Healthcare PharmaceuticalsAlofisel
Owned by Takeda Pharmaceutical Company
Prescription stem cell therapy originally approved in Europe for treating complex perianal fistulas in adult Crohn's disease patients, developed by TiGenix and acquired by Takeda.
gastroenterologycrohns-diseasefistula